Road‐map of pre‐clinical treatment for Visceral Leishmaniasis

Glutamine supplementation improves the efficacy of miltefosine treatment for visceral leishmaniasis

(2020) Carolina Ferreira et al.   PLoS Neglected Tropical Diseases

Kala-azar elimination in a highly-endemic district of Bihar, India: A success story

(2020) Vijay Kumar et al.   PLoS Neglected Tropical Diseases

Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs

(2020) Alec O’Keeffe et al.   Microorganisms

ANTILEISHMANIAL AMINOPYRAZOLES: STUDIES INTO MECHANISMS AND STABILITY OF EXPERIMENTAL DRUG RESISTANCE

(2020) M Van den Kerkhof et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Discovery and Characterization of Clinical Candidate LXE408 as a Kinetoplastid-Selective Proteasome Inhibitor for the Treatment of Leishmaniases

(2020) Advait Nagle et al.   JOURNAL OF MEDICINAL CHEMISTRY

Hamster, a close model for visceral leishmaniasis: Opportunities and challenges

(2020) Sheetal Saini et al.   PARASITE IMMUNOLOGY

A spatio-temporal approach to short-term prediction of visceral leishmaniasis diagnoses in India

(2020) Emily S. Nightingale et al.   PLoS Neglected Tropical Diseases

Xenodiagnosis to address key questions in visceral leishmaniasis control and elimination

(2020) Om Prakash Singh et al.   PLoS Neglected Tropical Diseases

Amphotericin B Loaded Polymeric Nanoparticles for Treatment of Leishmania Infections

(2020) Mudassara Saqib et al.   Nanomaterials

Central Asian Rodents as Model Animals for Leishmania major and Leishmania donovani Research

(2020) Barbora Vojtkova et al.   Microorganisms

A chronic bioluminescent model of experimental visceral leishmaniasis for accelerating drug discovery

(2019) Raquel Álvarez-Velilla et al.   PLoS Neglected Tropical Diseases

Visceral Leishmaniasis

(2019) Johan van Griensven et al.   INFECTIOUS DISEASE CLINICS OF NORTH AMERICA

Current and emerging medications for the treatment of leishmaniasis

(2019) Jaya Chakravarty et al.   EXPERT OPINION ON PHARMACOTHERAPY

Synthesis, In Silico, and In Vitro Evaluation of Anti-Leishmanial Activity of Oxadiazoles and Indolizine Containing Compounds Flagged against Anti-Targets

(2019) Strahinja Stevanovic et al.   MOLECULES

Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?

(2019) Luis Horrillo et al.   Parasites & Vectors

In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates

(2019) Sarah Hendrickx et al.   PLoS Neglected Tropical Diseases

Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: A candidate formulation for visceral leishmaniasis

(2018) Samanta Etel Treiger Borborema et al.   BIOMEDICINE & PHARMACOTHERAPY

Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages

(2018) Andrew A Voak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular Diagnosis of Visceral Leishmaniasis

(2018) Shyam Sundar et al.   Molecular Diagnosis & Therapy

Recent Development of Visceral Leishmaniasis Treatments: Successes, Pitfalls, and Perspectives

(2018) Fabiana Alves et al.   CLINICAL MICROBIOLOGY REVIEWS

Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis

(2018) Susan Wyllie et al.   NATURE

Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence

(2018) Shyam Sundar et al.   Expert Review of Anti-Infective Therapy

Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India

(2018) Vishal Goyal et al.   PLoS Neglected Tropical Diseases

Chemotherapeutics of visceral leishmaniasis: present and future developments

(2017) SHYAM SUNDAR et al.   PARASITOLOGY

Cellular Uptake and Movement in 2D and 3D Multicellular Breast Cancer Models of Fructose-Based Cylindrical Micelles That Is Dependent on the Rod Length

(2016) Jiacheng Zhao et al.   ACS Applied Materials & Interfaces

A ReplicativeIn VitroAssay for Drug Discovery against Leishmania donovani

(2016) Diana Tegazzini et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Antileishmanial Mechanism of Diamidines Involves Targeting Kinetoplasts

(2016) Gyongseon Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cationic Liposomal Sodium Stibogluconate (SSG), a Potent Therapeutic Tool for Treatment of Infection by SSG-Sensitive and -Resistant Leishmania donovani

(2014) Roma Sinha et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Activity of anti-cancer protein kinase inhibitors against Leishmania spp.

(2014) L. Sanderson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety and Efficacy of Single Dose versus Multiple Doses of AmBisome® for Treatment of Visceral Leishmaniasis in Eastern Africa: A Randomised Trial

(2014) Eltahir A. G. Khalil et al.   PLoS Neglected Tropical Diseases

Comparison of a High-Throughput High-Content Intracellular Leishmania donovani Assay with an Axenic Amastigote Assay

(2013) Manu De Rycker et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats

(2012) Fady Ibrahim et al.   DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Liposomal Amphotericin B for Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients: 2-Year Treatment Outcomes in Bihar, India

(2011) P. K. Sinha et al.   CLINICAL INFECTIOUS DISEASES

Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial

(2011) Shyam Sundar et al.   LANCET

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

(2010) Shyam Sundar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pentavalent Antimonials: New Perspectives for Old Drugs

(2009) Frédéric Frézard et al.   MOLECULES

Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®

(2009) J. L. Italia et al.   PHARMACEUTICAL RESEARCH

Three-dimensional Huh7 cell culture system for the study of Hepatitis C virus infection

(2009) Bruno Sainz et al.   Virology Journal